Hepatitis B surface antigen seroclearance after nucleos(t) ide analogue discontinuation in non-cirrhotic patients with chronic hepatitis B
Hepatology Forum · 2026 · 7 (4) · 337-344
DOI: 10.14744/hf.2026.12274 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hepatology Forum, 2026. Verfasst von Zeynep Melekoglu Ellik und 14 weiteren Autor:innen.
Abstract (Originalsprache)
Background and Aim: This study aimed to evaluate the clinical outcomes following the discontinuation of nucleos(t)ide analogue (NA) treatment in hepatitis B e antigen (HBeAg)-negative patients with chronic hepatitis B (CHB). Materials and Methods: This single-center retrospective cohort study included 146 non-cirrhotic patients with CHB who achieved long-term viral suppression under NA treatment. Seventy-three patients discontinued NA treatment, while a historical age- and sex-matched control group consisted of 73 patients who continued NA treatment. Results: Hepatitis B surface antigen (HBsAg) seroclearance occurred in eight patients (11%) in the treatment-discontinuation group, while none was observed in the treatment-contin-ued group (p = 0.004). The cumulative probability of HBsAg loss was 16.9% at month 120 after NA discontinuation. Firth-penalized Cox regression analysis identified younger age (
Zitieren
APA
Ellik, Z. M., Sah, F. T., Koc, O., Tunc, E., Yilmaz, V., Bodakci, E., Gumussoy, M., Ozercan, M., Er, R. E., Kiremitci, S., Elhan, A. H., Savas, B., Gokcan, H., Yurdaydin, C., & Idilman, R. (2026). Hepatitis B surface antigen seroclearance after nucleos(t) ide analogue discontinuation in non-cirrhotic patients with chronic hepatitis B. Hepatology Forum, 7(4), 337-344. https://doi.org/10.14744/hf.2026.12274
Vancouver
Ellik ZM, Sah FT, Koc O, Tunc E, Yilmaz V, Bodakci E, et al. Hepatitis B surface antigen seroclearance after nucleos(t) ide analogue discontinuation in non-cirrhotic patients with chronic hepatitis B. Hepatology Forum. 2026;7(4):337-344. doi:10.14744/hf.2026.12274
BibTeX
@article{Ellik2026,
author = {Ellik, Zeynep Melekoglu and Sah, Fatma Tugce and Koc, Ozge and Tunc, Esra and Yilmaz, Volkan and Bodakci, Emin and Gumussoy, Mesut and Ozercan, Mubin and Er, Ramazan Erdem and Kiremitci, Saba and Elhan, Atilla Halil and Savas, Berna and Gokcan, Hale and Yurdaydin, Cihan and Idilman, Ramazan},
title = {Hepatitis B surface antigen seroclearance after nucleos(t) ide analogue discontinuation in non-cirrhotic patients with chronic hepatitis B},
journal = {Hepatology Forum},
year = {2026},
volume = {7},
number = {4},
pages = {337--344},
doi = {10.14744/hf.2026.12274}
}
EUVIMED